Page 31

tute of Medicine Workshop on Possible Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, May 14.

Tingle AJ, Kettyls GDM, Ford DK. 1979. Studies on vaccine-induced rubella arthritis. Serologic findings before and after immunization. Arthritis and Rheumatism 22:400-402.

Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. 1985. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae and chronic rubella viremia. Journal of Infectious Diseases 152:606-612.

Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. 1986. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA27/3 rubella immunization. Annals of the Rheumatic Diseases 45:110-114.

Tondury G, Smith DW. 1965. Fetal rubella pathology. Journal of Pediatrics 68:867-879.

Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP, Panitch HS, Scott RA, Oshiro L, Cremer NE. 1975. Progressive rubella panencephalitis: late onset after congenital rubella. New England Journal of Medicine 292:990-993.

Veale H. 1866. History of an epidemic of rothein, with observation on its pathology. Edinburgh Medical Journal 12:404-414.

Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1972. Influence of age on clinical response to HPV-77 duck rubella vaccine. Journal of the American Medical Association 222:805-807.

Weil ML, Itabashi HH, Cremer NE, Oshiro LS, Lennette EH, Carnay L. 1975. Chronic progressive panencephalitis due to rubella virus stimulating subacute sclerosing panencephalitis. New England Journal of Medicine 292:994-998.

Weiss AA, Hewlett EL. 1986. Virulence factors of Bordetella pertussis. Annual Reviews of Microbiology 40:661-686.

Weiss AA, Hewlett EL, Myers GA, Falkow S. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors in Bordetella pertussis. Journal of Infectious Diseases 150:219-222.

Weller TH, Neva FA. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proceedings of the Society for Experimental Biology and Medicine 111:215-225.

Williams NM, Preblud SR. 1984. Rubella and congenital rubella surveillance, 1983. Centers for Disease Control Surveillance Summaries 33:1SS-10SS.

Wirsing von König CH, Hoppe JE, Tacken A, Finger H. 1990. Detection of Bordetella pertussis in clinical specimens. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services.

Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, Neill JS. 1969. Epidemiology of rubella. American Journal of Diseases of Children 118:107-112.

Zellweger H. 1959. Pertussis encephalopathy. Archives of Pediatrics 76:381-386.

Zellweger H, Steinegger R. 1950. Zur Klinik und Pathogenese der Pertussisencephalopathie. Helvetica Paediatrica Acta 5:139.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement